Literature DB >> 25228121

A clearer view of evidence in treating macular degeneration: off-label policies and independent research.

Giulio Formoso1, Anna Maria Marata, Nicola Magrini, Lisa Bero.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25228121     DOI: 10.1002/14651858.ED000090

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


× No keyword cloud information.
  3 in total

1.  Regulation of the pharmaceutical industry: promoting health or protecting wealth?

Authors:  Alan Maynard; Karen Bloor
Journal:  J R Soc Med       Date:  2015-04-28       Impact factor: 5.344

2.  Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004-2012: a quantitative and qualitative study of pharmaceutical industry self-regulation.

Authors:  Anna V Zetterqvist; Juan Merlo; Shai Mulinari
Journal:  PLoS Med       Date:  2015-02-17       Impact factor: 11.069

3.  A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015.

Authors:  William Hollingworth; Tim Jones; Barnaby C Reeves; Tunde Peto
Journal:  BMJ Open       Date:  2017-10-22       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.